1
项与 Anti-CEA CAR T cell therapy(Shanghai Genechem Co., Ltd.) 相关的临床试验An Open-label, Uncontrolled, Single-arm Pilot Study to Evaluate Safety and Efficacy of Intratumoral Delivery Mediated MG7-targeted Chimeric Antigen Receptor T Cells in Advanced MG7 Positive Liver Metastases
The purpose of this study is to collect the data on the safety and potential effectiveness of intra-tumor injection of MG7-CART cells under ultrasound guidance in patients with liver metastases expressing MG7 positively.
100 项与 Anti-CEA CAR T cell therapy(Shanghai Genechem Co., Ltd.) 相关的临床结果
100 项与 Anti-CEA CAR T cell therapy(Shanghai Genechem Co., Ltd.) 相关的转化医学
100 项与 Anti-CEA CAR T cell therapy(Shanghai Genechem Co., Ltd.) 相关的专利(医药)
100 项与 Anti-CEA CAR T cell therapy(Shanghai Genechem Co., Ltd.) 相关的药物交易